IDEXX provides diagnostic and software products and services for pet healthcare, self-described as a global leader in veterinary innovation.

IDEXX

IDEXX Animana

ezyVet

IDEXX Small Animal Health

IDEXX Water Testing

Livestock Diagnostics

10,000 people, one global focus﻿ - enhancing the health and well-being of pets, people, and livestockWe are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better. IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.

Venrock

IDEXX VetConnect® PLUS

IDEXX CardioPet

IDEXX rVetLink VetReferral

Pet Health Network

IDEXX SmartFlow

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

Google Font API

HSTS

Google Maps

Content Delivery Network

Owner

Adam Duemmling

Chief Compliance Officer

Alexandra Gaugler

Sr. Director, Associate General Counsel

Alexia Pappas

Independent Board Director

Asha Collins

Founder and Chief Organizer

Bettina Blanchard

Chief Technology Officer at IDEXX Laboratories

Bill Brown

Web Application Developer

Brad Candell

Evp, CFO

Brian McKeon

Operations

Casey Lutz

Parasitology Medical Lab Tech

Charles Williams

Anthony Evnin

Rebecca M. Henderson

Jefferson Bates

Senior Marketing and Customer Insights Manager

Khristopher Lalemand

Product Manager II

Sophie Vandebroek

Non-Executive Board Director

Tonia Nagle

Head of Customer Experience Growth Marketing

Aghasi Chitchyan

Sr. Director Finance

Tony Caola

Vice President, Global Lab Technology and Innovation and General Manager, IDEXX BioAnalytics

David Evans Shaw

Founder

Charlie White

Director and Product Management

Biotechnology Companies With More Than 1000 Employees

New England Public Companies With More Than $1M in Revenue

Maine Health Care Companies

Biotechnology Companies With More Than $1B in Revenue

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,900 people and offers products to customers in over 100 countries.

Seed Round - IDEXX Laboratories

Computer and Software Products and Electrical and Scientific Products

Westbrook

Maine

United States

North America

IDEXX Laboratories

North American Morning Briefing : Investors Look -2-

IDEXX Laboratories's Performance Over Last 10 Years

Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?

IDEXX Laboratories Announces Second Quarter Results

Idexx Laboratories initiated with bullish view at BTIG, here's why

IDEXX Laboratories to Release 2024 Second Quarter Financial Results

IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds

IDEXX Laboratories First Quarter 2024 Earnings: EPS Beats Expectations

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript

India

Asia

Australia

Oceania

Canada

Colombia

South America

HTML5

Comodo PositiveSSL Certificates

Wordpress

Modernizr

Google Analytics

Adobe Fonts

Facebook

Cloudflare CDN

Office 365

Vimeo

Fujirebio, fka Innogenetics, conceives, develops, produces and markets in vitro diagnostics (IVD) testing solutions.

F. Fujirebio

Vybion is a developer and manufacturer of recombinant proteins for therapeutic and diagnostic applications.

V. Vybion

IDEXX is a global leader in pet healthcare innovation, providing diagnostic and software products and services to enhance the health and well-being of pets, people, and livestock.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 15, 2024 5:55 PM	7eec296f
public peers	general	Oct 2, 2024 2:34 PM	91c295f7
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 2, 2024 2:34 PM	4c3238ce
crunchbase trigger	general	Nov 4, 2024 10:53 AM	f394ecb1
crunchbase profile	general	Nov 4, 2024 11:09 AM	5b0619dc
li profile	general	Feb 15, 2024 5:55 PM	9054650b
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	aebf8ceb
peers	general	Oct 2, 2024 2:34 PM	26763ed3
news basic	general	Oct 2, 2024 2:34 PM	f7c757cb
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:IDEXX

IDEXX